PB

Psyence Biomedical LtdNASDAQ PBM Stock Report

Last reporting period 30 Jun, 2023

Updated 24 Dec, 2024

Last price

Market cap $B

0.007

Micro

Exchange

XNAS - Nasdaq

View Section: Price ratios

Psyence Statements

PB

Data from Psyence`s earning releases including common size income statement and balance sheet.

Common size analysis evaluates financial statements by expressing each line item as a percentage of a base amount for that period.

Key Information:

Report currency:

USD - US dollar

Last reporting period:

30 Jun, 2023

Next reporting period:

28 Sep, 2023

Report frequency:

Quarterly

Earnings release date:

Expected release date:

Psyence Income Statement


Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

B

M

USD (except Earnings per share)

Financial

Revenue


Cost of sales


Gross profit


Research and development


Selling, general and administrative


Total operating expenses


Operating income


Interest expense


Other income


Income before tax


Provision for income taxes


Net income


Diluted earnings per share


Shares outstanding after dilution


2023-06-30
%

100

0

0

0

0.51

0

0.51

-33.8 %

0

-0.51

33.8 %

0

0.45

0

0

-0.06

-200 %

0

0

-0.06

-200 %

0

-0.01

8.04

2023-03-31
%

100

0

0

0

0.77

0

0.77

51 %

0

-0.77

-51 %

0

0.75

0

0

-0.02

-100.9 %

0

0

-0.02

-100.9 %

0

11.43

2022-12-31
%

100

0

0

0

0.51

0

0.51

218.8 %

0

-0.51

-218.8 %

0

2.76

0

0

2.25

192.2 %

0

0

2.25

192.2 %

0

0.05

45.1

2022-09-30
%

100

0

0

0

0.16

0

0.16

-44.8 %

0

-0.16

44.8 %

0

0.93

0

0

0.77

-62.3 %

0

0

0.77

-62.3 %

0

0.03

28.54

2022-06-30
%

100

0

0

0

0.29

0

0.29

-12.1 %

0

-0.29

12.1 %

0

2.34

0

0

2.04

-30.8 %

0

0

2.04

-30.8 %

0

0.07

28.54

2022-03-31
%

100

0

0

0

0.33

0

0.33

0

-0.33

0

3.28

0

0

2.95

0

0

2.95

0

0.1

28.54

View Section: Balance Sheet